Skip to content
Clinical Trials – home

Ofloxacin Hydrochloride: A Comprehensive Guide for Patients

2 / 2
trials open to patients / all trials
2+
Countries

In short

Ofloxacin Hydrochloride is an antibiotic medication that has been studied in various clinical trials for different medical conditions. This article explores the use of Ofloxacin Hydrochloride in clinical research, focusing on its effectiveness, potential applications, and comparison with other treatments. We'll examine trials involving this drug for conditions like bone and joint infections, diabetic foot ulcers, and as a prophylactic measure in certain medical procedures.

At a glance

Primary Uses in Trials
Bone and joint infections, diabetic foot ulcers, community-acquired pneumonia, pelvic inflammatory disease
Administration Methods
Oral tablets, typically 400 mg doses, frequency varies by condition
Comparative Studies
Compared with Levofloxacin, Nemonoxacin, and combinations with other antibiotics
Safety Considerations
Monitoring for toxicity in elderly patients, potential side effects under investigation
Promising Research Areas
Prophylaxis for procedures, optimizing dosing strategies, combination therapies
Patient Populations
Adults with various infections, elderly patients, diabetics with foot ulcers

What is Ofloxacin?

Ofloxacin is an antibiotic medication that belongs to a class of drugs called fluoroquinolones. It's also known by the brand name Floxin. Ofloxacin works by stopping the growth of bacteria, making it effective against various types of infections.

Medical Uses

Ofloxacin is used to treat a variety of bacterial infections. Based on the clinical trials data, it has been studied for use in the following conditions:

  • Diabetic Foot Ulcers: Ofloxacin has been used to treat infected diabetic foot ulcers. These are open sores that can occur on the feet of people with diabetes and can become infected with bacteria.
  • Bone and Joint Infections: Ofloxacin is considered a standard antibiotic for treating bone and joint infections, particularly those caused by susceptible strains of staphylococcus bacteria.
  • Pelvic Inflammatory Disease (PID): This is an infection of the female reproductive organs. Ofloxacin, often combined with metronidazole, has been used to treat PID.
  • Prostate Biopsy Prophylaxis: Ofloxacin has been studied as a preventive antibiotic before prostate biopsies to reduce the risk of infection.

How is Ofloxacin Administered?

The administration of ofloxacin can vary depending on the condition being treated. Here are some common methods:

  • Oral tablets: For many infections, ofloxacin is taken by mouth. For example, in the treatment of diabetic foot ulcers, patients were given 400 mg twice a day for 14 days.
  • Eye drops: While not mentioned in the provided clinical trials, ofloxacin is also available as eye drops for treating certain eye infections.
  • Ear drops: Similarly, ofloxacin can be used as ear drops, though this form wasn't discussed in the given trials.

Always follow your doctor's instructions regarding dosage and duration of treatment.

Potential Side Effects

Like all medications, ofloxacin can cause side effects. While the specific trials provided don't detail all potential side effects, it's important to be aware that they can occur. Some studies, such as the one on bone and joint infections in the elderly, specifically looked at the relationship between ofloxacin concentration in the blood and the occurrence of side effects.

Common side effects of fluoroquinolones like ofloxacin can include nausea, diarrhea, headache, and dizziness. More serious side effects, though rare, can include tendon problems, nerve damage, and changes in blood sugar. Always discuss potential side effects with your healthcare provider.

Comparisons with Other Antibiotics

Several studies have compared ofloxacin to other antibiotics:

  • Ofloxacin vs. MSI-78: In the treatment of infected diabetic foot ulcers, ofloxacin was compared to MSI-78, a topical antibiotic cream.
  • Ofloxacin + Metronidazole vs. Azithromycin + Metronidazole: For treating pelvic inflammatory disease, a combination of ofloxacin and metronidazole was compared to azithromycin and metronidazole.
  • Ofloxacin vs. Gentamicin: These antibiotics were compared for use as prophylaxis (preventive treatment) before prostate biopsies.

These comparisons help doctors understand which antibiotics work best for different conditions.

Ongoing Research

Research continues to explore the best uses and dosages for ofloxacin. For example, one study is investigating the relationship between the concentration of ofloxacin in the blood and the occurrence of side effects in elderly patients with bone and joint infections. This type of research helps doctors use the medication more effectively and safely.

Another area of research is comparing ofloxacin to newer antibiotics. For instance, a study compared ofloxacin to nemonoxacin, a newer antibiotic, for treating community-acquired pneumonia. While this study didn't focus solely on ofloxacin, it demonstrates how researchers continually seek to improve antibiotic treatments.

Questions people often ask

Conditions where Ofloxacin Hydrochloride is being studied

Each condition opens its own overview and trial list

Trials with Ofloxacin Hydrochloride

Recruiting trials first

See all 2 →
Quick filters
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).